(Q41117736)

English

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

scientific article published on April 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 September 2017

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses (English)

1 reference

Europe PubMed Central

27 September 2017

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

author name string

Hodge JW

1

1 reference

Europe PubMed Central

27 September 2017

McLaughlin JP

2

1 reference

Europe PubMed Central

27 September 2017

Kantor JA

3

1 reference

Europe PubMed Central

27 September 2017

Schlom J

4

1 reference

Europe PubMed Central

27 September 2017

language of work or name

0 references

publication date

1 April 1997

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

27 September 2017

15

1 reference

Europe PubMed Central

27 September 2017

759-768

1 reference

Europe PubMed Central

27 September 2017

6-7

1 reference

Europe PubMed Central

27 September 2017

Immunotherapeutic strategies for cancer using poxvirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Overcoming inhibition of antibody responses to a malaria recombinant vaccinia virus caused by prior exposure to wild type virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonreplicating viral vectors as potential vaccines: Recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy studies on a canarypox-rabies recombinant virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunisation with canarypox virus expressing rabies glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of cytotoxic T lymphocyte responses to SIV proteins in SIV-infected macaques using antigen-specific stimulation with recombinant vaccinia and fowl poxviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoembryonic antigen-transgenic mice: a model for tumor immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900238-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(96)00238-1

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

27 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41117736&oldid=2094068730"